Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DEAD-box helicase 18 pseudogene 1 (DDX18P1) is classified as a pseudogene, not a protein-coding gene or functional therapeutic target. Pseudogenes are typically non-functional segments of DNA similar to known genes but do not produce active proteins. This distinguishes DDX18P1 from DEAD-box helicase 18 (DDX18), which is an ATP-dependent RNA helicase implicated in RNA metabolism and regulation[1][6]. There is no evidence supporting DDX18P1's role in therapeutic targeting, disease association, or pharmacology, nor are there validated biological functions, interacting drugs, or clinical biomarkers. The main gene of interest for functional studies in this family is DDX18, not DDX18P1[1][6]. Summary of key points: - DDX18P1 is a pseudogene, not a functional gene. - It is not considered a therapeutic target and has no known biological or disease roles. - It should not be confused with DDX18, which is an active RNA helicase[1][6]. If you require details specifically about the functional DEAD-box helicase 18 (DDX18) and not its pseudogene, please clarify, as those answers would differ significantly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DEAD-box helicase 18 pseudogene 1 (DDX18P1).